欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0222/001
药品名称Flukiver Combi Oral Suspension
活性成分
    • closantel 75.0 mg/ml
    • mebendazole 50.0 mg/ml
剂型Oral suspension
上市许可持有人Eli Lilly & Company Limited Elanco Animal Health Lilly House Priestly Road Basingstoke Hampshire RG24 9NL Previous MAH - Janssen Pharmaceutica NV Turnhoutseweg 30 B-2340 Beerse Belgium
参考成员国 - 产品名称Ireland (IE)
Flukiver Combi Oral Suspension
互认成员国 - 产品名称
    • Germany (DE)
      Flukiver Combi
    • Belgium (BE)
    • Netherlands (NL)
    • Iceland (IS)
    • Austria (AT)
    • Greece (GR)
许可日期2009/05/27
最近更新日期2023/12/19
药物ATC编码
    • QP52AC09 mebendazole
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase